Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
Jay C HorrowWen LiManfred BlobnerJohn LombardMarcel SpeekMatthew DeAngelisW Joseph HerringPublished in: BMC anesthesiology (2021)
Registered on November 17, 2017, at ClinicalTrials.gov under number NCT03346070 .